
Read a refresh of breast cancer FDA news from June 2026, including several practice-changing approvals and the granting of priority review to a SERD.
Anna Weiss, MD, discusses the significance of various imaging modalities in patients with breast cancer.
“We’re finding more and more that axillary lymph node dissection can be avoided in many patients, especially those who undergo neoadjuvant therapy.”
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine, discusses the significance of various imaging modalities in patients with breast cancer, as well as reasons for the declining role of axillary lymph node dissection in this disease.





